Status:

RECRUITING

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 OUS Study)

Lead Sponsor:

Gradient Denervation Technologies

Conditions:

Pulmonary Hypertension

Eligibility:

All Genders

22-85 years

Phase:

NA

Brief Summary

Characterize the impact of pulmonary artery denervation on the quality of life in Heart Failure Patients with Group 2 Pulmonary Hypertension

Detailed Description

The Gradient Denervation System delivers ultrasound ablation to planned locations in the pulmonary artery to down-regulate the sympathetic nervous drive. The system includes a sterile, single-use cath...

Eligibility Criteria

Inclusion

  • Mean Pulmonary Artery Pressure (mPAP) \>20 mmHg at rest
  • Pulmonary Vascular Resistance (PVR) ≥ 3WU at rest
  • Pulmonary Capillary Wedge Pressure \> 15 mmHg (at rest) or \> 18 with passive leg raise
  • NYHA Class II or III
  • Glomerular Filtration Rate (GFR) ≥ 25 ml/min

Exclusion

  • Unwilling to provide informed consent or complete follow-up assessments
  • Life expectancy of \< 2 years
  • Inability to take dual antiplatelet or anticoagulants, hypersensitivity or allergy to aspirin or clopidogrel
  • Unable to tolerate right heart catheterization
  • Severe aortic, mitral or pulmonary valve regurgitation
  • Clot or Thrombus in any potential target ablation zone (right, left or main pulmonary artery)
  • Systemic infection or localized infection/rash at planned access site at time of procedure
  • CRT, ICD, Pacemaker or other Interventional cardiac procedure (except RHC) within the last 3 months

Key Trial Info

Start Date :

June 26 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2026

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT06495970

Start Date

June 26 2024

End Date

June 30 2026

Last Update

August 1 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Hospital Universitari Germans Trias i Pujol

Badalona, Spain, 08916

2

Hospital Universitari Vall d'Hebron

Barcelona, Spain, 08035

3

Hospital Clínico Universitario de Valencia

Valencia, Spain

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 OUS Study) | DecenTrialz